Table 2. Influence of either the NC or the noNC therapy on selected variables.

	noNC						NC
	Before Mean or median and SD or IQR		After Mean or median and SD or IQR		% change	p&	Before Mean or median and SD or IQR		After Mean or median and SD or IQR		% change
Total cholesterol, mg/dL	210	24	210	25	0.00	< 0.001	211	17	185	17	−12.32*
LDL cholesterol, mg/dL	131	16	132	18	0.76	< 0.001	134	14	105	15	−21.64*
HDL cholesterol, mg/dL	51	12	52	11	1.96	0.12	51	15	54	13	5.88
Triglycerides, mg/dL	110	72–186	103	78–154	−6.36	0.84	115	83–177	109	76–175	−5.21
Body mass index, kg/m2	26.7	3.9	26.6	3.8	−0.37	0.99	26.5	3.4	26.3	3.6	−0.75
Waist circumference, cm	88	11	89	9	1.13	0.83	90	11	91	12	1.11
hsCRP, mg/L	2.7	2.2−4.9	3.4	1.8−5.1	25.92	0.04	3.0	2.2−4.2	2.5	1.3–3.4	−16.67*
EMPs, n/microL	401	298–514	407	278–504	1.50	< 0.001	416	302–500	353	247–438	−15.14*

Values are mean ± standard deviation (SD) except for triglycerides, hsCRP and EMPs expressed as median and interquartile range (IQR). NC, nutraceutical combined therapy; LDL, low-density lipoprotein; HDL, high-density lipoprotein; hsCRP, high sensitivity C-reactive protein; EMPs, endothelial microparticles. *p < 0.05 for comparison between values at baseline and those after the NC treatment. ^&The p value is for the GLM comparison of variable variations after either NC or noNC treatment.